The Market Opportunity Peripheral Artery Disease (PAD) is a global health challenge with over 230 million people affected—1 in 3 diabetics over age 50 is at risk. Yet current diagnostic tools are often inadequate, especially for the diabetic foot, leading to more than one diabetes-related limb amputation every 20 seconds. The need for a practical, early-stage diagnostic solution is vast and urgent.
The Solution PedCheck™ is a patented, portable, non-invasive device designed to detect PAD early—before symptoms manifest. Leveraging proprietary near-infrared (NIR) light technology and AI-driven analytics, PedCheck™ identifies localized perfusion issues in the foot, enabling clinicians to intervene early and prevent amputation.
Why PedCheck™ Is Different
- Early, Accurate Detection: Identifies PAD and microvascular compromise before clinical symptoms arise.
- Accessibility: Inexpensive and intuitive enough for broad deployment—usable by physicians, podiatrists, nurses, and lab techs.
- Scalable Tech: Cloud-based software returns instant analysis, enabling remote care, data tracking, and integration into health systems.
- Versatility: Measures therapy effectiveness across interventions such as revascularization, offloading, or medication.
Validation and Progress PedCheck™ has completed a feasibility clinical trial with promising results, demonstrating high sensitivity and specificity in detecting PAD. The device is protected by several patents and is currently undergoing international pilot studies with a beta MVP.
The Investment Case
- Large, underserved market with global reach
- First-mover advantage in pre-ulcer, foot-specific PAD diagnostics
- Multiple revenue streams from hardware sales, SaaS subscriptions, and clinical partnerships
- Strong IP portfolio and clinical validation positioning it for regulatory pathways and strategic partnerships
Impact and Vision PedCheck™ is poised to redefine diabetic foot care—from reactive amputation treatment to proactive preservation. With the potential to improve outcomes, reduce healthcare costs, and save millions of limbs, PedCheck™ represents a powerful opportunity for financial and social impact.